Vifor Fresenius Medical Care Renal Pharma
Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.
-
New drug trial aims to keep kidney patients' potassium in check
Disease control CompletedThis study tested a medication called patiromer in Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely and effectively lower potassium, allowing patients to continue taking their important heart and kidney medication…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug trial targets debilitating itch for kidney patients
Symptom relief CompletedThis study tested whether a drug called difelikefalin could safely reduce the intensity of severe itching in Chinese adults receiving hemodialysis for kidney failure. 260 participants were randomly assigned to receive either the drug or a placebo (inactive substance) three times …
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC